Finance

Lists
002940:SHE
Zhejiang Anglikang Pharmaceutical Co Ltd
CNÂ¥25.95
-3.46%
(-0.93) 1D
Sep 7, 3:04:39 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002940...
Open
CNÂ¥26.66
High
CNÂ¥27.17
Low
CNÂ¥25.85
Mkt. cap
5.42B
Avg. vol.
11.51M
Volume
22.19M
Dividend
0.96%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 22, 2026
P/E ratio
46.17
52-wk high
CNÂ¥48.90
52-wk low
CNÂ¥23.11
EPS
CNÂ¥0.56
Shares outstanding
201.73M
No. of employees
1K
Open
CNÂ¥26.66
High
CNÂ¥27.17
Low
CNÂ¥25.85
Mkt. cap
5.42B
Avg. vol.
11.51M
Volume
22.19M
Dividend
0.96%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Jun 22, 2026
P/E ratio
46.17
52-wk high
CNÂ¥48.90
52-wk low
CNÂ¥23.11
EPS
CNÂ¥0.56
Shares outstanding
201.73M
No. of employees
1K
About Zhejiang Anglikang Pharmaceutical Co Ltd
CEO-
Employees1.24K
FoundedDec 30, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
330.81M
369.64M
340.16M
286.88M
Cost of goods sold
202.07M
221.21M
215.60M
166.49M
Cost of revenue
202.07M
221.21M
215.60M
166.49M
Research and development expenses
37.79M
22.18M
34.11M
30.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.63M
65.01M
61.98M
54.48M
Operating expense
104.52M
92.72M
94.14M
67.32M
Total operating expenses
306.59M
313.93M
309.73M
233.82M
Operating income
24.22M
55.71M
30.42M
53.06M
Other non operating income
-1.04M
692.58K
-2.27M
-359.36K
EBT including unusual items
17.80M
67.76M
24.18M
48.96M
EBT excluding unusual items
21.92M
56.31M
27.92M
52.93M
Income tax expense
396.68K
11.54M
792.30K
5.46M
Effective tax rate
2.23%
17.03%
3.28%
11.16%
Other operating expenses
3.62M
3.29M
-95.92K
-19.91M
Net income
11.76M
47.75M
17.65M
37.27M
Net profit margin
3.56%
12.92%
5.19%
12.99%
Earnings per share
-
-
-
-
Interest and investment income
3.40M
2.60M
2.78M
3.00M
Interest expense
-3.28M
-3.01M
-3.00M
-2.78M
Net interest expenses
120.15K
-403.65K
-224.39K
224.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
45.95M
74.90M
49.61M
71.93M
Gain or loss from assets sale
-53.31K
27.78K
-
-
AI content may include mistakes. Learn more
Google apps